2/28
01:30 am
ydes
Low
Report
2/25
08:00 am
ydes
YD Bio Limited Announces Strategic Partnership with YC Biotech Co., Ltd. to Establish a Taiwan-U.S. Dual-Core Regulatory Platform
Low
Report
YD Bio Limited Announces Strategic Partnership with YC Biotech Co., Ltd. to Establish a Taiwan-U.S. Dual-Core Regulatory Platform
1/29
08:42 am
ydes
YD Bio Limited Enters into Binding Letter of Intent to Acquire Safe Save Medical Cell Sciences & Technology Co., Ltd., Bolstering Leadership in Advanced Immunocell Therapy [Yahoo! Finance]
Low
Report
YD Bio Limited Enters into Binding Letter of Intent to Acquire Safe Save Medical Cell Sciences & Technology Co., Ltd., Bolstering Leadership in Advanced Immunocell Therapy [Yahoo! Finance]
1/29
08:30 am
ydes
YD Bio Limited Enters into Binding Letter of Intent to Acquire Safe Save Medical Cell Sciences & Technology Co., Ltd., Bolstering Leadership in Advanced Immunocell Therapy
High
Report
YD Bio Limited Enters into Binding Letter of Intent to Acquire Safe Save Medical Cell Sciences & Technology Co., Ltd., Bolstering Leadership in Advanced Immunocell Therapy
1/6
09:00 am
ydes
YD Bio Enters into MOU to Merge with EG BioMed, Advancing DNA Methylation–Driven AI Platforms for Cancer Diagnostics and Drug Development
High
Report
YD Bio Enters into MOU to Merge with EG BioMed, Advancing DNA Methylation–Driven AI Platforms for Cancer Diagnostics and Drug Development
1/5
09:00 am
ydes
YD Bio Limited Announces Major Milestones and Unveils Robust 2026 Clinical and Commercial Roadmap
Medium
Report
YD Bio Limited Announces Major Milestones and Unveils Robust 2026 Clinical and Commercial Roadmap
12/30
04:16 pm
ydes
True Velocity, Inc./DE (NASDAQ:YDES) had its "sell (d+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
True Velocity, Inc./DE (NASDAQ:YDES) had its "sell (d+)" rating reaffirmed by analysts at
Weiss Ratings.
12/24
04:16 am
ydes
True Velocity, Inc./DE (NASDAQ:YDES) is now covered by analysts at
Weiss Ratings. They set a "sell (d+)" rating on the stock.
Medium
Report
True Velocity, Inc./DE (NASDAQ:YDES) is now covered by analysts at
Weiss Ratings. They set a "sell (d+)" rating on the stock.
12/16
09:00 am
ydes
YD Bio Limited Expands U.S. Presence with Newly Planned California Facilities and Operations Center
Low
Report
YD Bio Limited Expands U.S. Presence with Newly Planned California Facilities and Operations Center
12/9
09:00 am
ydes
YD Bio Limited Showcases Its Innovative Diagnostic and Precision Medicine Portfolios at the 9th Healthcare EXPO TAIWAN
High
Report
YD Bio Limited Showcases Its Innovative Diagnostic and Precision Medicine Portfolios at the 9th Healthcare EXPO TAIWAN